Related Experiment Video
Updated: Apr 28, 2026
Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Marburg variant of multiple sclerosis: A young women case report
Mohammed Alaa Jameel1, Wameth Alaa Jamel2, Alaa Jameel Hasan3
1Royal Blackburn Teaching Hospital, East Lancashire Hospitals NHS Trust, East Lancashire, England, UK.
Abstract:
Marburg disease (malignant multiple sclerosis, MS) is a rare, acute MS variant, predominantly occurring among young adults. Because it is characterized by rarity, high morbidity and mortality rates, the disease needs to be further characterized, and the experience of the physicians play a role in treatment regimens. We report the case of a 15-years-old female presenting with progressive weakness over the limbs, hyperreflexia and loss of sensation by physical examination, lab tests and radiological investigations (MRI). After treatment, nonimprovement was recognized by symptoms review after IV corticosteroids, Gabapentin and Clonazepam intake during a clinical visit. IV corticosteroids, Gabapentin and Clonazepam are not sufficient treatment for Marburg's variant of multiple sclerosis disease. Therefore, aggressive therapies can be used to further suppress the inflammatory process to prevent further neurological damage.
Insights
Marburg disease, a severe multiple sclerosis variant, requires aggressive treatment. Standard therapies like corticosteroids and Gabapentin were insufficient for a young patient, highlighting the need for advanced interventions.
Area of Science:
- Neurology
- Immunology
- Clinical Case Study
Background:
- Marburg disease is a rare, acute variant of multiple sclerosis (MS) predominantly affecting young adults.
- It is characterized by high morbidity and mortality rates, necessitating further characterization and optimized treatment strategies.
- Physician experience significantly influences treatment decisions for this rare condition.
